ACTIVATION OF PPAR GAMMA RECEPTORS REDUCES LEVODOPA-INDUCED DYSKINESIAS IN 6-OHDA-LESIONED RATS

Long-term administration of L-3,4-dihydroxyphenylalanine (levodopa), the mainstay treatment for Parkinson’s disease (PD), is accompanied by fluctuations in its duration of action and motor complications (dyskinesia) that dramatically affect the quality of life of patients. Levodopa-induced dyskinesi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurobiol Dis
Asıl Yazarlar: Martinez, A. A., Morgese, M. G., Pisanu, A., Macheda, T., Paquette, M. A., Seillier, A., Cassano, T., Carta, A.R., Giuffrida, A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4323744/
https://ncbi.nlm.nih.gov/pubmed/25486547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2014.11.024
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller